Article Detail - JE Part B
Molecular Assays for the Diagnosis of Cutaneous Melanoma (DL39373) - Published for Review and Comments
This proposed Local Coverage Determination (LCD) has been published for review and comments for contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
Medicare Coverage Database (MCD) Number: DL39373
LCD Title: Molecular Assays for the Diagnosis of Cutaneous Melanoma
Comment period: July 07, 2022 - August 20, 2022
Visit the CMS MCD to access Proposed LCDs not released to final LCDs.
Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Proposed LCDs webpage for email and mail specifics.
Last Updated Tue, 12 Jul 2022 13:24:30 +0000